Northstar Neuroscience, Inc. (fka NSTR)

[sabre3]

This part does:


"Northstar Neuroscience has yet another style of neuromodulation technology that stimulates the outer surface of the brain, or cortex. The company had been pursuing the market for stroke rehabilitation, but announced last month that its key stroke trial failed, sending shares into a tailspin and raising questions about what the small company will do next.
Northstar is now considering using its cash and technology to explore treatment of severe depression or tinnitus - the perception of ringing in the ears - and has said it plans to say more later this month about what market it will pursue."